CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:INT-1B3, an LNP formulated miR-193a-3p mimic, promotes anti-tumor immunity by enhancing T cell mediated immune responses via modulation of the tumor microenvironment and induction of immunogenic cell death.
INT-1B3, an LNP formulated miR-193a-3p mimic, promotes anti-tumor immunity by enhancing T cell mediated immune responses via modulation of the tumor microenvironment and induction of immunogenic cell death.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
microRNAs(miRNAs)是一类小的非编码RNA,可调控多个基因的表达。MiR-193a-3p在多种癌症类型中发挥抑癌作用,但其诱导特异性抗肿瘤免疫应答的作用尚不清楚。
因此,我们研究了我们的脂质纳米颗粒(LNP)配制的、化学修饰的合成miR-193a-3p模拟物(INT-1B3)对抗肿瘤免疫的影响。INT-1B3抑制了远处肿瘤转移并显著延长了生存期。接受INT-1B3治疗的动物即使在没有治疗的情况下,也完全免受自体肿瘤细胞的攻击,表明存在长期免疫。对自体肿瘤细胞攻击的保护作用在T细胞耗竭后受到削弱,而过继性T细胞转移可抑制肿瘤生长。用我们的miR-193a-3p模拟物(1B3)转染肿瘤细胞导致肿瘤细胞死亡和凋亡,并伴随DAMPs表达增加。将1B3转染的肿瘤细胞与未成熟DC共培养可导致DC成熟,这些成熟DC能够刺激CD4+和CD8+ T细胞产生1型细胞因子。CD4-CD8- T细胞也产生1型细胞因子,甚至可直接响应1B3转染的肿瘤细胞。活细胞成像显示PBMC介导的对1B3转染肿瘤细胞的细胞毒性。这些数据首次证明,miR-193a-3p通过调节肿瘤微环境和诱导免疫原性细胞死亡,诱导针对肿瘤发展的长期免疫。
microRNAs (miRNAs) are small, non-coding RNAs that regulate expression of multiple genes. MiR-193a-3p functions as a tumor suppressor in many cancer types, but its effect on inducing specific anti-tumor immune responses is unclear.
Therefore, we examined the effect of our lipid nanoparticle (LNP) formulated, chemically modified, synthetic miR-193a-3p mimic (INT-1B3) on anti-tumor immunity. INT-1B3 inhibited distant tumor metastasis and significantly prolonged survival. INT-1B3-treated animals were fully protected against challenge with autologous tumor cells even in absence of treatment indicating long-term immunization. Protection against autologous tumor cell challenge was hampered upon T cell depletion and adoptive T cell transfer abrogated tumor growth. Transfection of tumor cells with our miR-193a-3p mimic (1B3) resulted in tumor cell death and apoptosis accompanied by increased expression of DAMPs.
Co-culture of 1B3-transfected tumor cells and immature DC led to DC maturation and these mature DC were able to stimulate production of type 1 cytokines by CD4+ and CD8+ T cells. CD4-CD8- T cells also produced type 1 cytokines, even in response to 1B3-transfected tumor cells directly.
Live cell imaging demonstrated PBMC-mediated cytotoxicity against 1B3-transfected tumor cells. These data demonstrate for the first time that miR-193a-3p induces long-term immunity against tumor development via modulation of the tumor microenvironment and induction of immunogenic cell death.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。